CCR2 is required for CD8-induced graft-versus-host disease. - Wikidata - awgldk - TriplyDB

CCR2 is required for CD8-induced graft-versus-host disease.

CCR2 is required for CD8-induced graft-versus-host disease.

http://www.wikidata.org/entity/Q35848441

about

CCL8 is a potential molecular candidate for the diagnosis of graft-versus-host disease Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors Nanocomposite treatment reduces disease and lethality in a murine model of acute graft-versus-host disease and preserves anti-tumor effects Acute graft-versus-host disease: a bench-to-bedside update.Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB-Controlled Oxidative Stress Responses In vivo two-photon imaging reveals monocyte-dependent neutrophil extravasation during pulmonary inflammation.The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease Allogeneic splenocyte transfer and lipopolysaccharide inhalations induce differential T cell expansion and lung injury: a novel model of pulmonary graft-versus-host disease.CCL2 blockade augments cancer immunotherapy.Donor and recipient chemokine receptor CCR5 genotype is associated with survival after bone marrow transplantation.Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth Involvement of Hofbauer cells and maternal T cells in villitis of unknown aetiology.Advances in graft-versus-host disease biology and therapy.Shift of graft-versus-host-disease target organ tropism by dietary vitamin A.Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation.Therapeutic benefit of bortezomib on acute graft-versus-host disease is tissue specific and is associated with interleukin-6 levels Monocyte chemoattractant protein-1 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cells.Role of C-C motif ligand 2 and C-C motif receptor 2 in murine pulmonary graft-versus-host disease after lipopolysaccharide inhalations.Absence of donor T-cell-derived soluble TNF decreases graft-versus-host disease without impairing graft-versus-tumor activity Organ-derived dendritic cells have differential effects on alloreactive T cells.PLZF confers effector functions to donor T cells that preserve graft-versus-tumor effects while attenuating GVHD Anti-CD3 preconditioning separates GVL from GVHD via modulating host dendritic cell and donor T-cell migration in recipients conditioned with TBI.Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation.Absence of P-selectin in recipients of allogeneic bone marrow transplantation ameliorates experimental graft-versus-host disease.Pharmacologic inhibition of PKCα and PKCθ prevents GVHD while preserving GVL activity in mice.Silencing CCR2 in Macrophages Alleviates Adipose Tissue Inflammation and the Associated Metabolic Syndrome in Dietary Obese Mice.NOD2 regulates hematopoietic cell function during graft-versus-host disease Acute graft-versus-host disease: from the bench to the bedside.Graft-versus-leukemia effect of nonmyeloablative stem cell transplantation.PKCtheta is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in mice.The role of chemokines in mediating graft versus host disease: opportunities for novel therapeutics.New ways to separate graft-versus-host disease and graft-versus-tumour effects after allogeneic haematopoietic stem cell transplantation.Dynamics of M1 macrophages in oral mucosal lesions during the development of acute graft-versus-host disease in rats.Recombinant IL-7/HGFβ hybrid cytokine separates acute graft-versus-host-disease from graft-versus-tumour activity by altering donor T cell trafficking.Lithothamnion muelleri controls inflammatory responses, target organ injury and lethality associated with graft-versus-host disease in mice.CCR2 regulates monocyte recruitment as well as CD4 T1 allorecognition after lung transplantation.Inhibition of 5-lipoxygenase alleviates graft-versus-host disease.The Role of Janus Kinase Signaling in Graft-Versus-Host Disease and Graft Versus Leukemia.

P2860

Q24644566-0247DC98-D7F9-482C-AAAA-9A03AF1191EE Q24647124-642C248B-462C-484E-B550-93C55BA3CC2B Q27310065-4C5CD2F1-0C8E-4A4B-A7DA-D732AF5EC095 Q27687130-47265EFC-F88A-4503-BBFF-D27B16938AC0 Q28271836-6749CB27-F7A1-457F-A6DB-A0B01AFAF967 Q30497142-1772AFE1-FA03-44A8-80A7-2C086FD3EB2B Q33559627-88902B47-FFF7-45FF-A84D-5F278719621A Q33638349-51246C11-41F5-487B-868A-8121FD2F5E9A Q33651427-CBF16820-A2F9-408A-9DC8-3210219485C5 Q33747313-B38B3787-31B5-4F5D-84EF-4E5EC7B41E39 Q33915046-87F5429F-0129-448F-A933-5B31FD9A602C Q33957273-0533925D-EF65-4905-B618-06297C118D6C Q34031916-0A0B9BCA-28DE-4D37-89F8-870AFC104955 Q34292981-778A8A18-97A6-4436-85C6-B301002E07CC Q34561047-F587FE13-1A9B-4780-A625-2869F609F237 Q34624143-525F5158-5646-4BBD-9332-FD27046AD3A4 Q34626551-4666E0A7-817A-4AAF-BEB0-549A24823939 Q34924856-D4AB1AE6-B094-4908-BB5C-0743D48F53C3 Q35900973-F41CF8F2-7ACF-46E9-B6D0-4494BD91C2DA Q36478458-FEF402B1-7842-42A9-BC3C-C3166FA3F1AA Q37068170-55CC37D1-005F-43F3-A6C2-ABBDC2573536 Q37071152-6CF9D85A-2976-49DF-AD3C-F0AD413253F7 Q37100759-645D1087-54CF-4D30-BA60-A574017D6A8D Q37119275-62F286FF-C91E-461B-A766-52EBE54491F9 Q37215167-068D5F8F-6F19-4887-94D6-86872E89499B Q37234557-1651F7FF-E73F-41B7-8EE2-CE4F4CC8853D Q37377427-6997B29F-D653-49C5-903E-94E5886E4ADF Q37420496-61449328-F8A4-4649-9CFA-06DDF0ABCDEB Q37445265-EDE87C5F-A07F-4A90-A6CF-37FC5EA5AC36 Q37452305-82911B1A-EEA8-4CF5-90A1-37DB53CFA442 Q37989141-2B8F3F57-27F8-48CC-A28B-6CD95E38ACA8 Q38057376-72D303A8-FD76-47CD-9309-379EB75A7970 Q38598016-D8A5CE64-BF86-46F1-AF95-78C929CC9BD7 Q38736579-F33D1286-C8B6-4C68-8423-12DB8CDB1598 Q39122603-177BFB26-5235-4F3B-A31A-6C37170D20E6 Q42559685-AC0833E8-F81C-4E25-9891-1045E961F5C8 Q47744316-16E0F5D0-B90A-40D4-B3A0-6FBAA8E4DFE4 Q49384876-A3A4341C-917E-4AB0-8741-BABBED9D82E9

P2860

CCR2 is required for CD8-induced graft-versus-host disease.

http://www.wikidata.org/entity/Q35848441

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

CCR2 is required for CD8-induced graft-versus-host disease.

@ast

CCR2 is required for CD8-induced graft-versus-host disease.

@en

type

label

CCR2 is required for CD8-induced graft-versus-host disease.

@ast

CCR2 is required for CD8-induced graft-versus-host disease.

@en

prefLabel

CCR2 is required for CD8-induced graft-versus-host disease.

@ast

CCR2 is required for CD8-induced graft-versus-host disease.

@en

P1433

Q35848441-A74339F4-FF1A-4A77-81BC-1B9F0A7C2C0F

P1476

Q35848441-E11924BB-FEAD-4A9E-98B5-E12E2910EA54

P2093

Q35848441-0271D0DC-D061-41E4-8E22-8DD8BAF1CBC1

Q35848441-08426C4F-A400-4FD9-9669-F528F4272B58

Q35848441-2166FB3B-9F40-47F2-9219-FBA6E8E6E845

Q35848441-42B583E0-DE5B-4160-B0BA-4A148514CEBD

Q35848441-4843D7F3-22C7-45D6-A406-E3C062B5BCD9

Q35848441-4E16985E-3907-4452-BA4B-79752BC92947

Q35848441-5AFB4545-F5A3-4E65-98D4-D90243A2DC4D

Q35848441-8666871B-F26D-4E60-B01B-A7222F91028C

Q35848441-9A048750-6FEF-409B-AC4B-5CF66FDD1955

Q35848441-A05C4D48-9B6B-4472-BDC2-3810ED66D829

P2860

Q35848441-03AA8C71-0B7D-4F21-82F4-DF3BC5DAF169

Q35848441-04A48BCD-A276-4E4E-81E6-28BDFDD88684

Q35848441-17951283-A560-4DEB-A447-95E42718359B

Q35848441-18149BD7-EFC9-4A8A-B66E-0D337A21B7DD

Q35848441-186DE95F-C0AE-4C62-9B96-913928C27BAD

Q35848441-200C1827-5464-4196-AB24-0485C22D6FE5

Q35848441-261E64F4-2EE1-4607-A1D9-DE2A92CB6ACA

Q35848441-287ACECA-7D93-42EC-92F5-ABC93CD45B83

Q35848441-2C6347F1-E2FB-46B9-8894-17F55A42304A

Q35848441-2EB4DAEF-13E1-4274-B65E-704CD303A2AD

P304

Q35848441-09C044AB-855F-4126-922F-BEA4934665DC

P31

Q35848441-81DC3F52-7BD4-4A3A-8FBE-74187EEB5768

P356

Q35848441-6A07CD01-E37C-4957-BC15-1C1F054159B4

P407

Q35848441-120FD97D-8F84-49C2-8CBF-C6705F5539B7

P433

Q35848441-3190D4BF-4105-424E-8FFC-D8DF8C66797D

P478

Q35848441-B2871657-3F9A-4430-AFC3-A437C1F33B14

P50

Q35848441-2D0AA4C0-EB05-4742-9334-5F7A853E519F

P577

Q35848441-DFA61865-D4D9-4C3D-8666-FF06942BEF01

P5875

Q35848441-8A0ACDDA-1E30-48DF-992C-FC213CEA2687

P698

Q35848441-661646B2-E766-4BBD-A7AC-E1A6664E30ED

P932

Q35848441-6D2C4A0E-4220-4105-9D56-FBD04DEC4B18

P356

BLOOD-2005-05-1860

P1433

P1476

CCR2 is required for CD8-induced graft-versus-host disease

@en

P2093

Adam A Kochman

http://www.w3.org/2001/XMLSchema#string

Chen Liu

http://www.w3.org/2001/XMLSchema#string

George F Murphy

http://www.w3.org/2001/XMLSchema#string

Glenn Heller

http://www.w3.org/2001/XMLSchema#string

Jeffrey M Eng

http://www.w3.org/2001/XMLSchema#string

Johannes L Zakrzewski

http://www.w3.org/2001/XMLSchema#string

Marcel R M van den Brink

http://www.w3.org/2001/XMLSchema#string

Onder Alpdogan

http://www.w3.org/2001/XMLSchema#string

Stephanie J Muriglan

http://www.w3.org/2001/XMLSchema#string

Teresa Ramirez-Montagut

http://www.w3.org/2001/XMLSchema#string

P2860

Chemokines and disease

Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant

Cancer and the chemokine network

Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice

CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis

CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 c

Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2.

T-Cell Function and Migration — Two Sides of the Same Coin

Leukocyte migration and graft-versus-host disease.

CCR2: from cloning to the creation of knockout mice.

P304

3322-3330

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2005-05-1860

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7708695

http://www.w3.org/2001/XMLSchema#string

P698

16037386

http://www.w3.org/2001/XMLSchema#string

P932

1895329

http://www.w3.org/2001/XMLSchema#string